N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer.

AIM To investigate the possible association between meat intake, cigarette smoking and N-acetyltransferase 2 (NAT2) genetic polymorphisms on colorectal cancer (CRC) risk. METHODS Patients with CRC were matched for gender and age to healthy controls. Meat intake and cigarette smoking were assessed using a specific frequency questionnaire. DNA was extracted from peripheral blood and the genotypes of the polymorphism were assessed by polymerase chain reaction-restriction fragment length polymorphism. Five NAT2 alleles were studied (WT, M1, M2, M3 and M4) using specific digestion enzymes. RESULTS A total of 147 patients with colorectal cancer (76 women and 90 men with colon cancer) and 212 controls were studied. The mean age of the two groups was 62 years. More than half the subjects (59.8% in the case group and 51.9% in the control group) were NAT2 slow acetylators. The odds ratio for colorectal cancer was 1.38 (95% CI: 0.90-2.12) in slow acetylators. Although the number of women was small (n = 76 in the case group), the cancer risk was found to be lower in intermediate (W/Mx) acetylators [odds ratio (OR): 0.55, 95% confidence interval (95% CI): 0.29-1.02]. This difference was not observed in men (OR: 0.56, 95% CI: 0.16-2.00). Among NAT2 fast acetylators (W/W or W/Mx), meat consumption more than 3 times a week increased the risk of colorectal cancer (OR: 2.05, 95% CI: 1.01-4.16). In contrast, cigarette smoking increased the risk of CRC among slow acetylators (OR: 1.97, 95% CI: 1.02-3.79). CONCLUSION The risk of CRC was higher among fast acetylators who reported a higher meat intake. Slow NAT2 acetylation was associated with an increased risk of CRC.

[1]  D. Nebert.  Transcription factors and cancer: an overview. , 2002, Toxicology.

[2]  M. Doll,et al.  Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1. , 2001, Pharmacogenetics.

[3]  A. Mittelman,et al.  Diet in the epidemiology of cancer of the colon and rectum. , 1978, Journal of the National Cancer Institute.

[4]  L. Tamer,et al.  N‐acetyltransferase 2 gene polymorphism in patients with colorectal carcinoma , 2006, Cell biochemistry and function.

[5]  D. Grant,et al.  Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. , 1990, DNA and cell biology.

[6]  H. Samaratunga,et al.  Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  J. Trent,et al.  Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2. , 2008, Current drug metabolism.

[8]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[9]  P. Vineis.  Cancer as an evolutionary process at the cell level: an epidemiological perspective. , 2003, Carcinogenesis.

[10]  Jack A. Taylor,et al.  Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. , 1993, Carcinogenesis.

[11]  V. Ribeiro,et al.  CYP3A4*1B and NAT2*14 Alleles in a Native African Population , 2003, Clinical chemistry and laboratory medicine.

[12]  Xiao-Feng Sun,et al.  Genetic polymorphisms of N-acetyltransferase 2 and colorectal cancer risk. , 2005, World journal of gastroenterology.

[13]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.

[14]  S. Gallinger,et al.  Red Meat Intake, Doneness, Polymorphisms in Genes that Encode Carcinogen-Metabolizing Enzymes, and Colorectal Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[15]  P. Vineis,et al.  Metabolic gene polymorphism frequencies in control populations. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  Edward Giovannucci,et al.  Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta‐analysis , 2009, International journal of cancer.

[17]  H. Autrup.  Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. , 2000, Mutation research.

[18]  Ya‐Wen Cheng,et al.  NAT2 Fast Acetylator Genotype is Associated with an Increased Risk of Colorectal Cancer in Taiwan , 2007, Diseases of the colon and rectum.

[19]  G. La Torre,et al.  GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study. , 2009, Anticancer research.

[20]  S. Kuriyama,et al.  Cigarette smoking and the risk of colorectal cancer among men: a prospective study in Japan , 2007, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[21]  M. Doll,et al.  Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  A. Tjønneland,et al.  Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer. , 2008, Cancer letters.

[23]  J. Little,et al.  N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. , 2000, American journal of epidemiology.